nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Increased Risk of Major Cardiovascular Events in Older Adults Taking Certain Atypical Antipsychotics
December 1, 2017   

A new study found that older adult patients taking certain antipsychotic with high or intermediate risk of metabolic side effects may face a higher incidence of major cardiovascular events....
 Continue reading (Members only)
FDA Approves a New Formulation of Buprenorphine
November 30, 2017   

The U.S. Food and Drug Administration (FDA) has approved a new monthly formulation of the drug buprenorphine for the treatment of opioid use disorder...
 Continue reading
Biomarker-Based Prognostic Models to Help Predict Conversion to Dementia
November 27, 2017   

Biomarkers for Alzheimer's disease have greatly enhanced our ability to differentially diagnose dementia and have allowed us to test novel treatments, but the optimal use of these biomarkers in clinical practice remains challenging. Fortunately, a recent study provides a biomarker-based prognostic models that may help determine Alzheimer's disease dementia and any type of dementia in patients with mild cognitive impairment at the individual level...
 Continue reading (Members only)
Heart Function May Correlate With Brain Function
November 24, 2017   

Studies have shown that poor cardiac health is associated with a significant increase in the risk for cognitive decline and dementia....
 Continue reading (Members only)
FDA Allows Marketing of Device to Curb Opioid-Withdrawal Symptoms
November 22, 2017   

The US Food and Drug Administration (FDA) has granted marketing authorization for an electric stimulation device to be used in the reduction of symptoms related to opioid withdrawal...
 Continue reading
Drinking in Adolescence May Alter Brain Development
November 20, 2017   

A recent study found initiating drinking during adolescence was associated with disordered normal brain growth trajectories....
 Continue reading (Members only)
Ex-NFL Player Confirmed as First Case of Chronic Traumatic Encephalopathy in Living Patient
November 17, 2017   

New research appears to confirm that positron emission tomography (PET) imaging tracer can identify the distinctive brain tau pathology of chronic traumatic encephalopathy (CTE) in a living person....
 Continue reading (Members only)
FDA Approves Pill That Digitally Tracks Adherence
November 13, 2017   

The US Food and Drug Administration (FDA), recently approved the first drug in the U.S. with a digital ingestion tracking system...
 Continue reading (Members only)
Disappointing Results for Deep Brain Stimulation in Treatment-Resistant Depression
November 10, 2017   

A recent prospective RCT trial was conducted to test the safety and efficacy of deep brain stimulation (DBS) of the subcallosal cingulate white matter for treatment-resistant depression...
 Continue reading (Members only)
Recall: Midazolam Injection, USP, 2 mg/2 mL
November 6, 2017   

A voluntary nationwide a recall has been recently issued on blister packages mislabeled of Midazolam Injection...
 Continue reading (Members only)
12345678910...
Top of Page